Doctor

Contact Info

  • Call: +91-0542-6917700
  • nucmed.mpmmcc@tmc.gov.in
  • RT Building 2nd Floor

Working Hours

  • Monday - Friday 9:00 AM - 5:00 PM
  • Saturday 9:00 AM - 2:00 PM
  • Sunday Weekoff

DEPARTMENT OF NUCLEAR MEDICINE

About

Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease (Theranostics). Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and Positron Emission Tomography or PET scans are the two most common imaging modalities in Nuclear Medicine.

The services provided by the department include:

  • The department has performed 8,058 PET/CT scans using various radiopharmaceuticals. It performed 2732 SPECT and general Nuclear Medicine studies. 142 Therapeutic procedures were performed for various cancers including thyroid, neuroendocrine tumors, and prostate cancers. 68Ga DOTANOC, 68Ga PSMA, 68Ga FAPI, 68Ga CXCR4 were introduced as new services in 2022. Lu177 DOTATATE, and Lu177 PSMA were introduced as new therapeutic procedures for neuroendocrine and prostate malignancies. The lab was set up to label Lu177 and DOTATATE or PSMA peptide in-house.

Research & Educational Activities:

The department supports research and educational activities for the development and growth of employees.

Research

  • Ongoing Projects:02
  • National Publications:02
  • International Publications:02
  • Number of Book/ Book Chapter Published:01

Achievements:

  1. International poster presentation on pediatric nasopharyngeal carcinoma in SIOP 2022, Barcelona, Spain.
  2. Invited talk on 'Cost effective imaging alternatives for newer centres' in ANMPICON 2022, Vadodara.
  3. Invited talk on 'PET/CT in woman's Onco imaging' in Womans onco-imaging CME 2022, Varanasi.
  4. Invited Panelist in Panel discussion on screening in lung cancer, NAPCON 2022, Varanasi.
  5. Invited Panelist in Panel discussion on management of thyroid cancer, SurgAhead 2022, Varanasi.
  6. Invited talk on Role of Radioacitve iodine in DTC, Thyroid cancer Web CME, Suchitra Cancer Care, 2022.
  7. Invited talk on Role of Lu177 PSMA therapy in prostate cancer, Prostate cancer Web CME, Suchitra Cancer Care, 2022.
  8. Dept became TMCs first centre to impart RSO level III (High Dose Therapy) certification since Dec 2022.

Copyright © 2026 HBCH & MPMMCC, Varanasi Last Updated on : 17-October-2026